GynoFiles

Osphena is a newly approved prescription medication for menopausal women with painful intercourse. Painful intercourse, or dysparunia, in menopausal women is due to the thinning and dryness of the vaginal walls. If a woman is experiencing more than painful intercourse it is called the post-menopausal vulvovaginal syndrome . The active ingredient in Osphena is ospemifene which was studied in three clinical trials. It is related to estrogen, and thus it is possible that it will thicken the lining tissue of the uterus. any women with post menopausal bleeding needs to contact her health care provider regarding that symptoms. Women who are using medication for vaginal atrophy. The Women's Health Practice Clinical Research Division wants to thank our research trial participants in the research trials for ospemifene, and hope they hear about the successful treatment. The medication can cause some vaginal discharge, and some women reported hot flashes and muscle spasms. The risk of having...

If you are around the age of menopause or beyond and you have painful intercourse you may have post-menopausal vaginal syndrome . Estrogen during the premenopausal years is important for walls of the vaginal and the tissues of the vulva to remain healthy. It is important for the whole urogenital tract to remain healthy, so even the urethra and the tissues near the anus can become affected when the levels of estrogen decline as women get older. With post-menopausal vaginal syndrome women may experience vaginal dryness, vaginal discharge, burning with urination, itching of the vaginal area, and itching of the area of tissue between the vagina and the rectum known as the perineum. In severe cases women will report bleeding after sex, bleeding after exercising or spot bleeding unexpectedly. If you have a pelvic exam you may be told by your gyno that you have vaginal atrophy which is a thinning and dryness of the vaginal walls. Lack of estrogen and the post-menopausal vaginal sy...